1Sielken, Inc., Bryan, Texas, USA.
Hormesis, a phenomenon where low doses of a substance can have beneficial effects, requires fundamental changes in quantitative risk assessment. This includes flexible dose-response models and better characterization of low-dose risks and uncertainties.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: